Merus N.V. financial data

Symbol
MRUS on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, 3584 Cm Utrecht, Netherlands
State of incorporation
Netherlands
Fiscal year end
December 31
Former names
Merus B.V. (to 5/23/2016)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 680 % +58.8%
Debt-to-equity 26.7 % -42.5%
Return On Equity -36.3 % +48%
Return On Assets -28.7 % +39.9%
Operating Margin -560 % -33.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.2M shares +36.8%
Common Stock, Shares, Outstanding 67.9M shares +36.1%
Entity Public Float 1.3B USD +26.1%
Common Stock, Value, Issued 6.86M USD +34.6%
Weighted Average Number of Shares Outstanding, Basic 61.9M shares +28%
Weighted Average Number of Shares Outstanding, Diluted 61.9M shares +28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 35.2M USD -14.6%
Research and Development Expense 165M USD +6.91%
General and Administrative Expense 67.1M USD +13.3%
Operating Income (Loss) -197M USD -14.3%
Nonoperating Income (Expense) 35M USD +398%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -162M USD +8.22%
Income Tax Expense (Benefit) 5.57M USD +218%
Net Income (Loss) Attributable to Parent -168M USD +6%
Earnings Per Share, Basic -2.88 USD/shares +25.8%
Earnings Per Share, Diluted -2.88 USD/shares +25.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 629M USD +523%
Marketable Securities, Current 158M USD -3.66%
Cash, Cash Equivalents, and Short-term Investments 287M USD -25.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.84M USD -35%
Other Assets, Current 1.71M USD -16.7%
Assets, Current 807M USD +185%
Deferred Income Tax Assets, Net 543K USD -82.2%
Property, Plant and Equipment, Net 12.1M USD -7.35%
Operating Lease, Right-of-Use Asset 10.3M USD -13.9%
Other Assets, Noncurrent 2.13M USD -47.5%
Assets 892M USD +145%
Accounts Payable, Current 4.4M USD -42.1%
Employee-related Liabilities, Current 4.27M USD +14.8%
Accrued Liabilities, Current 38.5M USD +8.13%
Liabilities, Current 80.9M USD +22.8%
Operating Lease, Liability, Noncurrent 9.33M USD -16.4%
Liabilities 145M USD +36.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -38.9M USD -45.6%
Retained Earnings (Accumulated Deficit) -838M USD -25%
Stockholders' Equity Attributable to Parent 747M USD +190%
Liabilities and Equity 892M USD +145%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -44.4M USD -20.8%
Net Cash Provided by (Used in) Financing Activities 30.2M USD +13797%
Net Cash Provided by (Used in) Investing Activities -12.1M USD -43.7%
Common Stock, Shares Authorized 105M shares +55.6%
Common Stock, Shares, Issued 67.9M shares +36.1%
Common Stock, Par or Stated Value Per Share 0.09 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26.1M USD +42.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 630M USD +519%
Deferred Tax Assets, Valuation Allowance 173M USD +33.4%
Deferred Tax Assets, Gross 177M USD +31.1%
Operating Lease, Liability 12.2M USD -9.74%
Payments to Acquire Property, Plant, and Equipment 63K USD -98.3%
Lessee, Operating Lease, Liability, to be Paid 14.4M USD +14343%
Property, Plant and Equipment, Gross 19.9M USD +14.2%
Operating Lease, Liability, Current 1.69M USD +4.85%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.22M USD +3.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.21M USD -2.99%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 2.51M USD +61.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.28M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.79M USD -17.7%
Deferred Tax Assets, Operating Loss Carryforwards 162M USD +46.3%
Deferred Federal Income Tax Expense (Benefit) 1.78M USD +61.3%
Current Income Tax Expense (Benefit) 3.06M USD -33.1%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD -9.71%
Operating Lease, Payments 2.17M USD -21.4%
Current State and Local Tax Expense (Benefit) 916K USD -32.1%
Current Federal Tax Expense (Benefit) 2.14M USD -33.5%
Amortization of Intangible Assets 46K USD -14.8%
Depreciation, Depletion and Amortization 561K USD +5.06%
Deferred Tax Assets, Net of Valuation Allowance 4.2M USD -22.3%
Share-based Payment Arrangement, Expense 30.5M USD +23.3%
Deferred State and Local Income Tax Expense (Benefit) 736K USD +61.2%